Biocept Inc.

Biocept Inc.
Stock Exchange NASDAQ Stock Market
Market Cap
$39.1 M
Shares Outstanding
18.87 M
Public Float
11.58 M


5810 Nancy Ridge Drive
San Diego California 92121
United States
Employees -
Updated 07/08/2019
Biocept, Inc. is an oncology laboratory service company, which focuses on the development and marketing of novel laboratory products in the detection of rare cells to include circulating tumor cells. It develops and commercializes proprietary circulating tumor cell and circulating tumor DNA tests utilizing a standard blood sample. The company utilizes cell enrichment and extraction technology for the detection and analysis of circulating tumor DNA tests.


View All

David F. Hale
Non-Executive Chairman
Michael W. Nall
President, Chief Executive Officer & Director